Sofocure v

Sofocure V is an oral fixed-dose combination of sofosbuvir, a nucleotide analog NS5B polymerase inhibitor, and velapatasvir, an NS5A replication complex inhibitor. Sofosbuvir is approved for the... read more
  • Brand: Emcure
  • Active substance Sofosbuvir and Velpatasvir
  • Brand Sofocure v
  • Manufacture Emcure

265.00 USD
- +
Share

SOFOCURE V

Drug profile

Sofocure V (Sofosbuvir 400Mg + Velpatasvir 100Mg
Sofosbuvir 400Mg: Sofosbuvir is a nucleotide analog hepatitis C Virus non-structural protein 5B Polymerase inhibitor.
Velpatasvir 100Mg: Velpatasvir is a Hepatitis C Virus NS5A Inhibitor.
Sofocure V may also be used in combination with ribavirin for patients with advanced cirrhosis. Sofocure V is not recommended for use in patients with a known history of hepatitis B infection due to the increased risk of serious adverse reactions.

Mode of action

Sofocure V is an oral fixed-dose combination of sofosbuvir, a nucleotide analog NS5B polymerase inhibitor, and velapatasvir, an NS5A replication complex inhibitor. Sofosbuvir is approved for the treatment of genotype 1, 2, 3 and 4 HCV infection with different regimens and durations depending on the HCV genotype.

Indication

Fixed-Dose Combination Of Sofosbuvir And Velpatasvir is indicated for the treatment of adult patients with chronic hepatitis c virus, Genotype 1,2,3,4,5, or 6 infections:
1. With Cirrhosis Or With Compensated Cirrhosis.
2. With Decompensated Cirrhosis For Use In Combination with Ribavirin.

Dosage And Administration

The recommended dosage is one tablet taken orally, once daily with or without food.

Contraindication

Hypersensitivity to the sofosbuvir or velpatasvir or to any of the Excipient of the product.
Sofosbuvir and velpatasvir with ribavirin combination regimen are contraindicated inpatient for whom ribavirin is contraindicated.

Adverse reaction

1. Upper respiratory tract infection
2. Weight decreased
3. Insomnia
4. Dizziness
5. Headache
6. Hot flush
7. Dyspnoea
8. Nausea
9. Vomiting
10. Myalgia
11. Fatigue
12. Sunburn

Shelf Life

24Month

Storage And Handling

1. Store Protected From Moisture At a Temperature Not Exceeding 30Degree C.
2. Keep Container Tightly Closed.
3. Keep Out Of Reach Of Children.
4. Dispense In Original Container.

  • Sofosbuvir and Velpatasvir
  • Sofocure v
  • Emcure
  • India
    No comments yet
Write a comment
Your name
Your name
Captcha

Sale of day

Choice of buyers. Only popular options!Choice of buyers.
Only popular options!

view all
Abbott
Astella
bayer
BDR
Biocon
Cipla
Dr. Reddy’s
Eisai
Eisai Pharma
Emcure
everest
Glenmark
GSK
Hetero
incepta
Intas
MSD
Mylan
Natco
Novartis
Strides
Sun Pharma
Zydus
  • Children born with HIV
    Children born with HIV
    Children born with HIV accessing treatment, have no significant difference in their movement skills, social interaction, language skills or practical reasoning at age five compared to HIV-negative children, according to new research....